152 related articles for article (PubMed ID: 38325652)
1. Dose optimization and target attainment of vancomycin in children.
Cafaro A; Stella M; Mesini A; Castagnola E; Cangemi G; Mattioli F; Baiardi G
Clin Biochem; 2024 Mar; 125():110728. PubMed ID: 38325652
[TBL] [Abstract][Full Text] [Related]
2. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
3. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Allegaert K; Flint R; Smits A
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
[No Abstract] [Full Text] [Related]
5. VANCOmycin dose adjustments comparing trough levels to the ratio of the area under de curve to the minimum inhibitory concentration method using a BAYESian approach: A feasibility study.
Bilodeau V; Huot J; Perreault C; Haraoui LP; Delorme C; Poudrette J; Marsot A; Crevier B
J Clin Pharm Ther; 2022 Dec; 47(12):2335-2344. PubMed ID: 36461655
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
[TBL] [Abstract][Full Text] [Related]
7. Individualized dosing of vancomycin in geriatric patients.
Suchánková H; Lečbychová K; Strojil J; Fürst T
Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
[TBL] [Abstract][Full Text] [Related]
8. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
Pai MP; Neely M; Rodvold KA; Lodise TP
Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
[TBL] [Abstract][Full Text] [Related]
9. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
10. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.
Wong S; Selby PR; Reuter SE
Pharmacol Res Perspect; 2024 Aug; 12(4):e1231. PubMed ID: 38940223
[TBL] [Abstract][Full Text] [Related]
11. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis.
Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J
Clin Pharmacol Ther; 2021 Jan; 109(1):212-221. PubMed ID: 33190285
[TBL] [Abstract][Full Text] [Related]
13. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
14. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
15. Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients.
Shen K; Yang M; Fan Y; Liang X; Chen Y; Wu J; Yu J; Zhang H; Wang R; Zhang F; Hang J; Wen X; Li H; Shen L; Zhang Z; Wu S; Shen B; Huang W; Chang C; Shen Y; Ren H; Yuan Q; Song X; Luo X; Zhang H; Yang W; Yang J; Zhang J
Clin Infect Dis; 2018 Nov; 67(suppl_2):S256-S262. PubMed ID: 30423042
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
[TBL] [Abstract][Full Text] [Related]
17. Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis.
Yu Z; Liu J; Yu H; Zhou L; Zhao Y; Zhong L; Zhu J; Liang G; Yang Y; Zheng Y; Yu L; Han G
Int J Antimicrob Agents; 2023 Jun; 61(6):106812. PubMed ID: 37037321
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study.
Nolan J; McCarthy K; Farkas A; Avent ML
Int J Clin Pharm; 2023 Dec; 45(6):1444-1451. PubMed ID: 37532840
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and pharmacodynamics of antibiotics in septic children treated with extracorporeal membrane oxygenation].
Zhang HX; Huang JT; Dong J; Gong TZ; Zhang KY; Lu XL; Guo SW
Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):631-636. PubMed ID: 37385807
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients.
Morales Junior R; Juodinis VD; de Souza DC; Santos SRCJ
Braz J Infect Dis; 2023; 27(6):103688. PubMed ID: 37977199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
